Table 5.
Synergistic effect of Arthrospira maxima IFRPD 1183 extracted under 80% (v/v) ethanolic extraction and donepezil (Alzheimer’s disease drug).
| Samples | % Inhibition of BACE-1 | |||
|---|---|---|---|---|
| Donepezil | A. maxima | Experimental Value (EV) | Theoretical Value (TV) | Interpretation |
| IC10 (5 µg/mL) | 12.65 ± 0.27 | |||
| IC20 (10 µg/mL) | 20.02 ± 2.23 | |||
| IC30 (20 µg/mL) | 29.00 ± 0.35 | |||
| IC10 (3 µg/mL) | 12.20 ± 0.51 | |||
| IC20 (6 µg/mL) | 19.41 ± 0.13 | |||
| IC30 (16 µg/mL) | 31.65 ± 1.94 | |||
| IC10 (5 µg/mL) | IC10 (3 µg/mL) | 29.56 ± 1.29 | 12.43 | synergism |
| IC10 (5 µg/mL) | IC20 (6 µg/mL) | 29.81 ± 0.35 | 16.03 | synergism |
| IC10 (5 µg/mL) | IC30 (16 µg/mL) | 38.03 ± 1.15 | 22.15 | synergism |
| IC20 (10 µg/mL) | IC10 (3 µg/mL) | 24.99 ± 0.41 | 16.11 | synergism |
| IC20 (10 µg/mL) | IC20 (6 µg/mL) | 30.85 ± 1.90 | 19.72 | synergism |
| IC20 (10 µg/mL) | IC30 (16 µg/mL) | 42.47 ± 0.03 | 25.84 | synergism |
| IC30 (20 µg/mL) | IC10 (3 µg/mL) | 26.14 ± 0.37 | 20.83 | synergism |
| IC30 (20 µg/mL) | IC20 (6 µg/mL) | 37.92 ± 0.71 | 24.21 | synergism |
| IC30 (20 µg/mL) | IC30 (16 µg/mL) | 46.36 ± 1.07 | 30.33 | synergism |
Experimental values are displayed as mean ± standard deviation (SD) of triplicated experiments (n = 3).